Education
About Us
Working with TipRanks
Follow Us
Alpha Tau Medical Ltd (DRTS)
NASDAQ:DRTS
Total Valuation
Alpha Tau Medical Ltd has a market cap or net worth of $261.72M. The enterprise value is ―.
Market Cap$261.72M
Enterprise Value―
Share Statistics
Alpha Tau Medical Ltd has 84,699,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding84,699,720
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alpha Tau Medical Ltd’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is 35.22%.
Return on Equity (ROE)-0.35
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)35.22%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee0.00
Profits Per Employee-233.26K
Employee Count125
Asset Turnover0.00
Inventory Turnover-56.53
Valuation Ratios
The current PE Ratio of Alpha Tau Medical Ltd is -7.14. Alpha Tau Medical Ltd’s PEG ratio is 0.61.
PE Ratio-7.14
PS Ratio0.00
PB Ratio2.80
Price to Fair Value2.46
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.61
Income Statement
In the last 12 months, Alpha Tau Medical Ltd had revenue of 0.00 and earned -29.16M in profits. Earnings per share was -0.42.
Revenue0.00
Gross Profit-1.07M
Operating Income35.68M
Pretax Income-29.14M
Net Income-29.16M
EBITDA-28.03M
Earnings Per Share (EPS)-0.42
Cash Flow
In the last 12 months, operating cash flow was -3.78K and capital expenditures 0.00, giving a free cash flow of -3.78K billion.
Operating Cash Flow-3.78K
Free Cash Flow-3.78K
Free Cash Flow per Share>-0.01
Dividends & Yields
Alpha Tau Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change31.49%
50-Day Moving Average2.76
200-Day Moving Average2.75
Relative Strength Index (RSI)57.27
Average Volume (3m)51.60K
Important Dates
Alpha Tau Medical Ltd upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMay 19, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date―
Financial Position
Alpha Tau Medical Ltd as a current ratio of 12.07, with Debt / Equity ratio of 20.00%
Current Ratio12.07
Quick Ratio12.08
Debt to Market Cap0.03
Net Debt to EBITDA-0.02
Interest Coverage Ratio914.87
Taxes
In the past 12 months, Alpha Tau Medical Ltd has paid 16.00K in taxes.
Income Tax16.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Alpha Tau Medical Ltd EV to EBITDA ratio is -7.45, with an EV/FCF ratio of -8.57.
EV to Sales0.00
EV to EBITDA-7.45
EV to Free Cash Flow-8.57
EV to Operating Cash Flow-11.62
Balance Sheet
Alpha Tau Medical Ltd has $71.03M in cash and marketable securities with $12.56M in debt, giving a net cash position of -$58.47M billion.
Cash & Marketable Securities$71.03M
Total Debt$12.56M
Net Cash-$58.47M
Net Cash Per Share-$0.69
Tangible Book Value Per Share$1.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alpha Tau Medical Ltd is $7.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.33
Price Target Upside137.22% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast-8.07%